WallStreetZenWallStreetZen

NASDAQ: CTMX
Cytomx Therapeutics Inc Stock Ownership - Who owns Cytomx Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cytomx Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Lloyd A. RowlandGeneral Counsel2024-08-204,181$1.23
$5.14kSell
Jeffrey B. LandauChief Business Officer2024-08-204,181$1.23
$5.14kSell
Marcia BelvinSVP Chief Scientific Officer2024-08-204,181$1.23
$5.14kSell
Christopher OgdenChief Financial Officer2024-08-201,984$1.23
$2.44kSell
Sean A. McCarthyCEO2024-08-2013,898$1.23
$17.08kSell
Sean A. McCarthyCEO2024-03-26109,768$1.58
$172.88kBuy
Sean A. McCarthyCEO2024-03-1920,223$2.09
$42.19kSell
Marcia BelvinSVP Chief Scientific Officer2024-03-1912,795$2.09
$26.69kSell
Jeffrey B. LandauChief Business Officer2024-03-196,562$2.09
$13.69kSell
Christopher OgdenSVP Finance and Accounting2024-03-192,971$2.09
$6.20kSell

1 of 2

CTMX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTMX insiders and whales buy or sell their stock.

CTMX Shareholders

What type of owners hold Cytomx Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Tang Capital Management LLC9.97%7,791,936$9.58MInstitution
Janus Henderson Group PLC8.07%6,301,983$7.75MInstitution
Bvf Inc6.69%5,228,461$6.43MInstitution
Kevin P. Starr6.66%5,201,767$6.40MInsider
Vanguard Group Inc6.26%4,892,302$6.02MInstitution
Timothy M. 1. Shannon5.84%4,563,247$5.61MInsider
Robert I. Tepper5.57%4,349,864$5.35MInsider
Adage Capital Partners GP LLC3.84%3,000,000$3.69MInstitution
Acadian Asset Management LLC3.49%2,728,569$3.36MInstitution
Canaan Ix LP3.19%2,494,381$3.07MInsider

1 of 3

CTMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTMX64.89%26.88%Net SellingNet Selling
CASI0.44%99.56%
RENB9.61%78.54%Net SellingNet Selling
TLSA0.91%0.00%
KPTI54.16%30.17%Net SellingNet Selling
View Top Biotech Stocks

Cytomx Therapeutics Stock Ownership FAQ

Who owns Cytomx Therapeutics?

Cytomx Therapeutics (NASDAQ: CTMX) is owned by 64.89% institutional shareholders, 26.88% Cytomx Therapeutics insiders, and 8.24% retail investors. Kevin P. Starr is the largest individual Cytomx Therapeutics shareholder, owning 5.20M shares representing 6.66% of the company. Kevin P. Starr's Cytomx Therapeutics shares are currently valued at $6.40M.

If you're new to stock investing, here's how to buy Cytomx Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.